These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23746190)

  • 1. Pharmacogenomic biomarkers for personalized medicine.
    Chen JJ; Lin WJ; Chen HC
    Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic biomarkers: new tools in current and future drug therapy.
    Sim SC; Ingelman-Sundberg M
    Trends Pharmacol Sci; 2011 Feb; 32(2):72-81. PubMed ID: 21185092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and public health: implementing 'populationalized' medicine.
    Mette L; Mitropoulos K; Vozikis A; Patrinos GP
    Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD; Wagner JA
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.
    Zineh I; Huang SM
    Biomark Med; 2011 Dec; 5(6):705-13. PubMed ID: 22103607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
    Umićević Mirkov M; Coenen MJ
    Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.